
United States · Research startup
Bionaut Labs is a biotechnology company based in Los Angeles, California, focused on advancing the treatment of central nervous system (CNS) diseases.
Funding reportedLast round: Series B
Bionaut Labs is a biotechnology company based in Los Angeles, California, focused on advancing the treatment of central nervous system (CNS) diseases.
The company develops precision micro-technology, specifically microscale robots known as BionautsTM, which are designed to deliver therapies directly to targeted areas in the brain. These robots can navigate complex pathways within the body, enabling localized treatment for severe brain disorders. The BionautTM platform includes various applications such as delivering therapeutics, performing micro-biopsies, and enabling microsurgical procedures. Bionaut Labs has received significant regulatory designations from the FDA, including Humanitarian Use Device status for its micro-robot designed to treat Dandy-Walker Malformation and Orphan Drug Designation for a combination therapy targeting malignant glioma. The company aims to expand its focus beyond neuro-oncology to include areas like neuro-regeneration and pain management, positioning itself as a leader in remote-controlled micro-robot technology.
Funding, as reported
What they build
Known for
health carebiotechnology researchbiological sensingmedical research & developmentenergy storagewireless controlneuro-oncology treatmentbiomarker detectionmicro-robotic technologyautomated guidance systemtargeted therapydiagnostic monitoringmicro-robotic platformhydrocephalus therapyhospital & health careneuro-oncology applications
Built with from their website
Google Tag ManagerDropboxHTTP/2Cloudflare DNSGoogle WorkspaceZoom MeetingsCloudFlareViewport MetaGoogle AnalyticsVimeo
Google Analytics 4Amazon AWSAmazon S3Microsoft Exchange OnlineCloudFlare CDNMicrosoft ExchangeMicrosoft 365Outlook
Add your raise, your deck and your story, and put Bionaut Labs in front of investors. Or tell us what we have wrong.